Most recently, it's been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds into a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and does not activate a next m… Read More